An average of $3.9 billion per year in avoidable healthcare utilization costs would be realized if all U.S. adults older than 55 years diagnosed with age-related eye disease were to use lutein and zeaxanthin dietary supplements at preventive intake levels, according to a new economic report released Thursday by the Council for Responsible Nutrition.
MyFitnessPal on Thursday published its first user data study, uncovering a new trend in which people share health-related goals, activities and personal health content with their friends, colleagues and relatives, online and off.
Seattle Mayor Ed Murray on Thursday unveiled a plan to increase the city’s minimum wage to $15. Although Murray said the hike has broad support across local government, business and labor communities, the City Council still has to vote on the proposal.
GlaxoSmithKline on Wednesday announced that the Food and Drug Administration approved Incruse Ellipta (umeclidinium), which is used for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, or COPD, including chronic bronchitis and/or emphysema.
LeapFrog Enterprises, which specializes in educational entertainment for children, on Thursday announced the introduction of LeapBand, the first wearable activity tracker designed for kids that encourages active play and healthy habits.
Purdue Pharma on Wednesday announced that it filed a new drug application with the Food and Drug Administration to market a hydrocodone bitartrate tablet, which is formulated to incorporate abuse-deterrent technology.
Jubilant Life Sciences, an integrated pharmaceuticals and life sciences company, last week announced that it received approval from the Food and Drug Administration for spironolactone tablets, 25 mg, 50 mg and 100 mg, which is the generic version of Aldactone.
Walgreens announced the launch of the 2014 Walgreens Way to Well Health Tour with AARP, an outreach program that provides free preventive and early detection health services to communities across the country.
GlaxoSmithKline and Theravance on Monday announced that Anoro Ellipta (umeclidinium and vilanterol inhalation powder), a once-daily that combines two long-acting bronchodilators in a single inhaler, is now available in retail pharmacies in the United States.
Debbie Allen, an Emmy-award winning actress and choreographer is teaming up with dancers from the television dance competition "So You Think You Can Dance" and Janssen Pharmaceuticals to launch T2 Dance Crew, a national education and wellness program that encourages people with Type 2 diabetes to increase physical activity as part of managing their condition.
Johnson & Johnson on Monday hosted a 30-minute walk-through of the Johnson & Johnson Health & Wellness Experience. Over the course of the presentation, J&J executives showcased a number of consumer and corporate wellness initiatives implemented by J&J, including its Corporate Athlete Program, the 7-Minute Workout app, the Digital Health Scorecard app and the Care4today app.
Mylan last week announced that it filed suit against the Food and Drug Administration, challenging the agency's decision regarding generic drug marketing exclusivity on celecoxib capsules, the generic equivalent of Pfizer's Celebrex.
The National Association of Chain Drug Stores on Monday announced that it had elected new officers, one new executive committee member and three new board of directors members for the coming year during its annual meeting this weekend.
U.S. pharmaceutical firm Pfizer this morning confirmed discussions with AstraZeneca regarding a possible merger. If the transaction goes through, it's expected that the two companies will combine under a new U.K-incorporated holding company.
The Centers for Disease Control and Prevention on Thursday reported that vaccinations will prevent more than 21 million hospitalizations and more than 700,000 deaths among children born in the last two decades.